AU2002312788B2 - Dihydro-benzo [b] [1, 4] diazepin-2-one derivatives as mGluR2 antagonists II - Google Patents
Dihydro-benzo [b] [1, 4] diazepin-2-one derivatives as mGluR2 antagonists II Download PDFInfo
- Publication number
- AU2002312788B2 AU2002312788B2 AU2002312788A AU2002312788A AU2002312788B2 AU 2002312788 B2 AU2002312788 B2 AU 2002312788B2 AU 2002312788 A AU2002312788 A AU 2002312788A AU 2002312788 A AU2002312788 A AU 2002312788A AU 2002312788 B2 AU2002312788 B2 AU 2002312788B2
- Authority
- AU
- Australia
- Prior art keywords
- phenyl
- methyl
- acid tert
- amino
- butyl ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102100036837 Metabotropic glutamate receptor 2 Human genes 0.000 title description 7
- 108010038421 metabotropic glutamate receptor 2 Proteins 0.000 title description 3
- 239000005557 antagonist Substances 0.000 title description 2
- 238000000034 method Methods 0.000 claims description 678
- 150000001875 compounds Chemical class 0.000 claims description 601
- -1 3-oxo-piperazin-l-yl Chemical group 0.000 claims description 396
- 125000000217 alkyl group Chemical group 0.000 claims description 63
- 239000002253 acid Substances 0.000 claims description 55
- 125000003545 alkoxy group Chemical group 0.000 claims description 52
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 28
- 150000003839 salts Chemical class 0.000 claims description 23
- AZIZBYRGIGKTLW-UHFFFAOYSA-N 1,4-diazepin-2-one Chemical compound O=C1C=NC=CC=N1 AZIZBYRGIGKTLW-UHFFFAOYSA-N 0.000 claims description 19
- 229910052736 halogen Inorganic materials 0.000 claims description 17
- 150000002367 halogens Chemical class 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 13
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 13
- 125000001153 fluoro group Chemical group F* 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 208000028017 Psychotic disease Diseases 0.000 claims description 8
- 230000001154 acute effect Effects 0.000 claims description 8
- 125000004414 alkyl thio group Chemical group 0.000 claims description 8
- 230000001684 chronic effect Effects 0.000 claims description 8
- 208000024827 Alzheimer disease Diseases 0.000 claims description 7
- 208000026139 Memory disease Diseases 0.000 claims description 7
- 208000010877 cognitive disease Diseases 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 201000000980 schizophrenia Diseases 0.000 claims description 7
- 208000012902 Nervous system disease Diseases 0.000 claims description 6
- 208000025966 Neurological disease Diseases 0.000 claims description 6
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 238000007363 ring formation reaction Methods 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000003282 alkyl amino group Chemical group 0.000 claims description 3
- 125000005605 benzo group Chemical group 0.000 claims description 3
- 238000010511 deprotection reaction Methods 0.000 claims description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- OHWFEQKMVFNWLV-UHFFFAOYSA-N 7-(dimethylamino)-8-methyl-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 OHWFEQKMVFNWLV-UHFFFAOYSA-N 0.000 claims description 2
- PUMGQYZLUWHXDO-UHFFFAOYSA-N 8-methyl-7-[methyl(2-methylpropyl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 PUMGQYZLUWHXDO-UHFFFAOYSA-N 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims description 2
- 125000002971 oxazolyl group Chemical group 0.000 claims description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000000335 thiazolyl group Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- QDKZHQGXPVFLHU-UHFFFAOYSA-N 1,5-benzodiazepin-2-one Chemical compound O=C1C=CN=C2C=CC=CC2=N1 QDKZHQGXPVFLHU-UHFFFAOYSA-N 0.000 claims 2
- 150000002431 hydrogen Chemical group 0.000 claims 2
- ZVAPWJGRRUHKGP-UHFFFAOYSA-N 1h-1,5-benzodiazepine Chemical compound N1C=CC=NC2=CC=CC=C12 ZVAPWJGRRUHKGP-UHFFFAOYSA-N 0.000 claims 1
- DJMZLSQXQSZBAN-UHFFFAOYSA-N 4-[2-oxo-7-(2,2,2-trifluoroethoxy)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(OCC(F)(F)F)=CC=2N=C1C1=CC=NC(C#N)=C1 DJMZLSQXQSZBAN-UHFFFAOYSA-N 0.000 claims 1
- ASXHDONHHPHYRD-UHFFFAOYSA-N 4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-2-oxo-7-piperidin-1-yl-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound O1N=C(C)C=C1C1=CC=CC(C=2CC(=O)NC3=CC(=C(N4CCCCC4)C=C3N=2)C#N)=C1 ASXHDONHHPHYRD-UHFFFAOYSA-N 0.000 claims 1
- OWPXWLMWINGIJA-UHFFFAOYSA-N 4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-7-[methyl(propyl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 OWPXWLMWINGIJA-UHFFFAOYSA-N 0.000 claims 1
- MOZPRFSXXYUWQA-UHFFFAOYSA-N 4-[3-[5-(azetidin-1-ylmethyl)triazol-1-yl]phenyl]-8-chloro-7-[methyl(2-methylpropyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCC1 MOZPRFSXXYUWQA-UHFFFAOYSA-N 0.000 claims 1
- MMFHASXGTDQSPH-UHFFFAOYSA-N 4-[7-[methyl(propan-2-yl)amino]-2-oxo-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-4-yl]pyridine-2-carbonitrile Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C(C)C)=CC=2N=C1C1=CC=NC(C#N)=C1 MMFHASXGTDQSPH-UHFFFAOYSA-N 0.000 claims 1
- VYNUPTPNOCSSBJ-UHFFFAOYSA-N 7-(diethylamino)-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-2-oxo-1,3-dihydro-1,5-benzodiazepine-8-carbonitrile Chemical compound C1C(=O)NC=2C=C(C#N)C(N(CC)CC)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 VYNUPTPNOCSSBJ-UHFFFAOYSA-N 0.000 claims 1
- DDDRVKGHRFVCSK-UHFFFAOYSA-N 7-(dimethylamino)-4-(3-imidazol-1-ylphenyl)-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1C=CN=C1 DDDRVKGHRFVCSK-UHFFFAOYSA-N 0.000 claims 1
- GGCLCUPVAHZUHM-UHFFFAOYSA-N 7-[methyl(propan-2-yl)amino]-4-[3-[5-(pyrrolidin-1-ylmethyl)triazol-1-yl]phenyl]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CN1CCCC1 GGCLCUPVAHZUHM-UHFFFAOYSA-N 0.000 claims 1
- ADOSEGKIEQRXKL-UHFFFAOYSA-N 8-chloro-4-[3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]phenyl]-7-[methyl(propyl)amino]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)CCC)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CO)=CS1 ADOSEGKIEQRXKL-UHFFFAOYSA-N 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 230000000926 neurological effect Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 description 378
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 323
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 198
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 142
- 239000000203 mixture Substances 0.000 description 134
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 124
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 123
- 150000002148 esters Chemical class 0.000 description 120
- 239000003921 oil Substances 0.000 description 108
- 235000019198 oils Nutrition 0.000 description 108
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 107
- 239000000243 solution Substances 0.000 description 93
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 86
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 82
- 239000000460 chlorine Substances 0.000 description 78
- 238000006243 chemical reaction Methods 0.000 description 74
- 239000012267 brine Substances 0.000 description 64
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 64
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 63
- 239000006260 foam Substances 0.000 description 63
- MEGIEGFVRNXYSU-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(dimethylamino)-4-(trifluoromethyl)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F MEGIEGFVRNXYSU-UHFFFAOYSA-N 0.000 description 60
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 59
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 57
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 57
- 239000000463 material Substances 0.000 description 52
- 235000019439 ethyl acetate Nutrition 0.000 description 47
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 44
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 43
- ZTCGGBIFOFASKI-UHFFFAOYSA-N tert-butyl acetate;lithium Chemical compound [Li].CC(=O)OC(C)(C)C ZTCGGBIFOFASKI-UHFFFAOYSA-N 0.000 description 43
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 42
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 41
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 38
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 36
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 35
- 239000000741 silica gel Substances 0.000 description 35
- 229910002027 silica gel Inorganic materials 0.000 description 35
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 34
- 239000012044 organic layer Substances 0.000 description 33
- JTBNUOXTNBABIE-UHFFFAOYSA-N tert-butyl 3-[3-[5-(oxan-2-yloxymethyl)triazol-1-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2C(=CN=N2)COC2OCCCC2)=C1 JTBNUOXTNBABIE-UHFFFAOYSA-N 0.000 description 33
- 239000003480 eluent Substances 0.000 description 32
- PVCLQUXXFKCAPM-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-(dimethylamino)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl PVCLQUXXFKCAPM-UHFFFAOYSA-N 0.000 description 32
- 230000009467 reduction Effects 0.000 description 31
- BSPODPDIDGXFDC-UHFFFAOYSA-N tert-butyl 3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoate Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 BSPODPDIDGXFDC-UHFFFAOYSA-N 0.000 description 31
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 30
- 239000002904 solvent Substances 0.000 description 28
- QQJNABOVYNTCRV-UHFFFAOYSA-N tert-butyl 3-(2-cyanopyridin-4-yl)-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=NC(C#N)=C1 QQJNABOVYNTCRV-UHFFFAOYSA-N 0.000 description 28
- 239000000126 substance Substances 0.000 description 26
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 22
- 238000003756 stirring Methods 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
- 238000004587 chromatography analysis Methods 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 238000005984 hydrogenation reaction Methods 0.000 description 18
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 17
- 238000010898 silica gel chromatography Methods 0.000 description 17
- 239000011734 sodium Substances 0.000 description 17
- 229940093499 ethyl acetate Drugs 0.000 description 16
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 15
- 238000010992 reflux Methods 0.000 description 15
- 239000008279 sol Substances 0.000 description 15
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 14
- UZERPUAWQOHXES-UHFFFAOYSA-N tert-butyl n-(4-cyano-5-fluoro-2-nitrophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(F)=C(C#N)C=C1[N+]([O-])=O UZERPUAWQOHXES-UHFFFAOYSA-N 0.000 description 14
- ZCGIEZPJGKROLT-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[methyl(2-methylpropyl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F ZCGIEZPJGKROLT-UHFFFAOYSA-N 0.000 description 14
- 238000001914 filtration Methods 0.000 description 13
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 13
- HBZIEGPYQSSOGV-UHFFFAOYSA-N 1h-diazepine-7-carbonitrile Chemical compound N#CC1=CC=CC=NN1 HBZIEGPYQSSOGV-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 12
- IIZCUVHOPYPQGS-UHFFFAOYSA-N (4,5-dichloro-2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC(Cl)=C(Cl)C=C1[N+]([O-])=O IIZCUVHOPYPQGS-UHFFFAOYSA-N 0.000 description 11
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 11
- CXXUSSYNGZCIJB-UHFFFAOYSA-N tert-butyl 3-oxo-3-[3-(triazol-1-yl)phenyl]propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 CXXUSSYNGZCIJB-UHFFFAOYSA-N 0.000 description 11
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 11
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- KUHMJDSOPHMSDX-UHFFFAOYSA-N ethyl 3-oxo-3-[3-(triazol-1-yl)phenyl]propanoate Chemical compound CCOC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 KUHMJDSOPHMSDX-UHFFFAOYSA-N 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- JAELLLITIZHOGQ-UHFFFAOYSA-N tert-butyl propanoate Chemical compound CCC(=O)OC(C)(C)C JAELLLITIZHOGQ-UHFFFAOYSA-N 0.000 description 10
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical class NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 9
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 9
- BSQWYELDCUXPSJ-UHFFFAOYSA-N methyl 3-azidobenzoate Chemical compound COC(=O)C1=CC=CC(N=[N+]=[N-])=C1 BSQWYELDCUXPSJ-UHFFFAOYSA-N 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- 235000019260 propionic acid Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- NWHKKDLPTKZXQK-UHFFFAOYSA-N 1,2-dioxin-4-one Chemical compound O=C1COOC=C1 NWHKKDLPTKZXQK-UHFFFAOYSA-N 0.000 description 8
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 8
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 8
- KPASUWYIMLKUGR-UHFFFAOYSA-N 4-[3-[5-(hydroxymethyl)triazol-1-yl]phenyl]-7-[methyl(propan-2-yl)amino]-8-(trifluoromethyl)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C(F)(F)F)C(N(C)C(C)C)=CC=2N=C1C(C=1)=CC=CC=1N1N=NC=C1CO KPASUWYIMLKUGR-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 8
- GVWISOJSERXQBM-UHFFFAOYSA-N n-methylpropan-1-amine Chemical compound CCCNC GVWISOJSERXQBM-UHFFFAOYSA-N 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- NJGOKCQKYUXLSX-UHFFFAOYSA-N tert-butyl 3-(3-cyanophenyl)-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C#N)=C1 NJGOKCQKYUXLSX-UHFFFAOYSA-N 0.000 description 8
- SWEAKJSASQXXAU-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-[methyl(2-methylpropyl)amino]phenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl SWEAKJSASQXXAU-UHFFFAOYSA-N 0.000 description 8
- ISKUUZNVPWUNTC-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(dimethylamino)-4-fluorophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1F ISKUUZNVPWUNTC-UHFFFAOYSA-N 0.000 description 8
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 8
- DDDLKPMKDKTKJQ-UHFFFAOYSA-N 1-[methyl(2-methylpropyl)amino]-8-(trifluoromethyl)-3H-1,5-benzodiazepin-2-one Chemical compound C(C(C)C)N(C)N1C2=C(N=CCC1=O)C=CC(=C2)C(F)(F)F DDDLKPMKDKTKJQ-UHFFFAOYSA-N 0.000 description 7
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 7
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- 229910004373 HOAc Inorganic materials 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 7
- 239000000969 carrier Substances 0.000 description 7
- 239000000543 intermediate Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 150000004702 methyl esters Chemical class 0.000 description 7
- WDKOTVLVDWHHLW-UHFFFAOYSA-N tert-butyl n-(5-chloro-4-methyl-2-nitrophenyl)carbamate Chemical compound CC1=CC([N+]([O-])=O)=C(NC(=O)OC(C)(C)C)C=C1Cl WDKOTVLVDWHHLW-UHFFFAOYSA-N 0.000 description 7
- KRWKPWWLGUDSOV-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-(2-methylpropylamino)phenyl]carbamate Chemical compound CC(C)CNC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl KRWKPWWLGUDSOV-UHFFFAOYSA-N 0.000 description 7
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 7
- SUNMBRGCANLOEG-UHFFFAOYSA-N 1,3-dichloroacetone Chemical compound ClCC(=O)CCl SUNMBRGCANLOEG-UHFFFAOYSA-N 0.000 description 6
- ISFBZABEMYJJCF-UHFFFAOYSA-N 1-[methyl(2-methylpropyl)amino]-3h-1,5-benzodiazepin-2-one Chemical compound N1=CCC(=O)N(N(C)CC(C)C)C2=CC=CC=C21 ISFBZABEMYJJCF-UHFFFAOYSA-N 0.000 description 6
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 description 6
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 description 6
- 235000019502 Orange oil Nutrition 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 125000006316 iso-butyl amino group Chemical group [H]N(*)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 239000010502 orange oil Substances 0.000 description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 6
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- FEPASYFSULWDNV-UHFFFAOYSA-N tert-butyl 3-(3-imidazol-1-ylphenyl)-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2C=NC=C2)=C1 FEPASYFSULWDNV-UHFFFAOYSA-N 0.000 description 6
- UJFGZNBJAVEEGG-UHFFFAOYSA-N tert-butyl 3-oxo-3-(3-pyrazol-1-ylphenyl)propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=CC=C2)=C1 UJFGZNBJAVEEGG-UHFFFAOYSA-N 0.000 description 6
- QJRUGCDPBLUQTE-UHFFFAOYSA-N tert-butyl 3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 QJRUGCDPBLUQTE-UHFFFAOYSA-N 0.000 description 6
- CHCLFKQUCNAXTK-UHFFFAOYSA-N tert-butyl n-[2-amino-4-(2,3-difluorophenyl)-5-(dimethylamino)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C1=CC=CC(F)=C1F CHCLFKQUCNAXTK-UHFFFAOYSA-N 0.000 description 6
- FAJRXWKLPIBEDN-UHFFFAOYSA-N tert-butyl n-[2-amino-4-(2-fluorophenyl)-5-(2,2,2-trifluoroethoxy)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(OCC(F)(F)F)=C1C1=CC=CC=C1F FAJRXWKLPIBEDN-UHFFFAOYSA-N 0.000 description 6
- XMWVNQVJVMIVMK-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[methyl(propan-2-yl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F XMWVNQVJVMIVMK-UHFFFAOYSA-N 0.000 description 6
- XETDEUBKAJMXJS-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-iodo-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1I XETDEUBKAJMXJS-UHFFFAOYSA-N 0.000 description 6
- HXZFITILXOESLM-UHFFFAOYSA-N tert-butyl n-[5-chloro-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(Cl)=C(C(F)(F)F)C=C1[N+]([O-])=O HXZFITILXOESLM-UHFFFAOYSA-N 0.000 description 6
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 5
- QKEFOVJZNPELQH-UHFFFAOYSA-N 3-(2-bromoacetyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)CBr)=C1 QKEFOVJZNPELQH-UHFFFAOYSA-N 0.000 description 5
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 5
- 239000001828 Gelatine Substances 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 5
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- LVRJAFUTXDBMCM-UHFFFAOYSA-N methyl 3-(2-bromopropanoyl)benzoate Chemical compound COC(=O)C1=CC=CC(C(=O)C(C)Br)=C1 LVRJAFUTXDBMCM-UHFFFAOYSA-N 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- XHFGWHUWQXTGAT-UHFFFAOYSA-N n-methylpropan-2-amine Chemical compound CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- AVXDDDSVQMREIQ-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-[2-methoxyethyl(methyl)amino]phenyl]carbamate Chemical compound COCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl AVXDDDSVQMREIQ-UHFFFAOYSA-N 0.000 description 5
- UBXMQARTMWZVEP-UHFFFAOYSA-N tert-butyl n-[2-amino-4-cyano-5-(dimethylamino)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#N UBXMQARTMWZVEP-UHFFFAOYSA-N 0.000 description 5
- FIRRBISFFRMYNX-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(azetidin-1-yl)-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCC2)=C1C(F)(F)F FIRRBISFFRMYNX-UHFFFAOYSA-N 0.000 description 5
- VTVFCTSEAINUQK-UHFFFAOYSA-N tert-butyl n-[2-amino-5-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1C(F)(F)F VTVFCTSEAINUQK-UHFFFAOYSA-N 0.000 description 5
- HIHLPWFEZHZXPD-UHFFFAOYSA-N tert-butyl n-[5-fluoro-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(F)=C(C(F)(F)F)C=C1[N+]([O-])=O HIHLPWFEZHZXPD-UHFFFAOYSA-N 0.000 description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- COULAOZTCJTHOX-UHFFFAOYSA-N (2-amino-2-sulfanylideneethyl) 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCC(N)=S COULAOZTCJTHOX-UHFFFAOYSA-N 0.000 description 4
- RNEVREZJAWDXDT-UHFFFAOYSA-N (4-iodo-2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC=C(I)C=C1[N+]([O-])=O RNEVREZJAWDXDT-UHFFFAOYSA-N 0.000 description 4
- DPZNOMCNRMUKPS-UHFFFAOYSA-N 1,3-Dimethoxybenzene Chemical compound COC1=CC=CC(OC)=C1 DPZNOMCNRMUKPS-UHFFFAOYSA-N 0.000 description 4
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 4
- WXHAKCASYYCJED-UHFFFAOYSA-N 3-imidazol-1-ylbenzoic acid Chemical compound OC(=O)C1=CC=CC(N2C=NC=C2)=C1 WXHAKCASYYCJED-UHFFFAOYSA-N 0.000 description 4
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 4
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 4
- 239000005711 Benzoic acid Substances 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 101001071429 Homo sapiens Metabotropic glutamate receptor 2 Proteins 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000027089 Parkinsonian disease Diseases 0.000 description 4
- 206010034010 Parkinsonism Diseases 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000000010 aprotic solvent Substances 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- IGSKHXTUVXSOMB-UHFFFAOYSA-N cyclopropylmethanamine Chemical compound NCC1CC1 IGSKHXTUVXSOMB-UHFFFAOYSA-N 0.000 description 4
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 4
- DIZFWJVCPSJKGW-UHFFFAOYSA-N ethyl 3-ethynylbenzoate Chemical compound CCOC(=O)C1=CC=CC(C#C)=C1 DIZFWJVCPSJKGW-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 230000026045 iodination Effects 0.000 description 4
- 238000006192 iodination reaction Methods 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 4
- ULHKMSVNVCQHHX-UHFFFAOYSA-N methyl 3-(2,5-dimethyl-1,3-thiazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(C)=N2)C)=C1 ULHKMSVNVCQHHX-UHFFFAOYSA-N 0.000 description 4
- ZKRMSRDPBCGOLE-UHFFFAOYSA-N methyl 3-(2-bromopentanoyl)benzoate Chemical compound CCCC(Br)C(=O)C1=CC=CC(C(=O)OC)=C1 ZKRMSRDPBCGOLE-UHFFFAOYSA-N 0.000 description 4
- MCUGUUDHGRYPAG-UHFFFAOYSA-N methyl 3-(5-methyl-1,3-thiazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC=N2)C)=C1 MCUGUUDHGRYPAG-UHFFFAOYSA-N 0.000 description 4
- QKYWADPCTHTJHQ-UHFFFAOYSA-N n,2-dimethylpropan-1-amine Chemical compound CNCC(C)C QKYWADPCTHTJHQ-UHFFFAOYSA-N 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- RAFPNQXZTPWERJ-UHFFFAOYSA-N tert-butyl n-(2-amino-4-cyano-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1C#N RAFPNQXZTPWERJ-UHFFFAOYSA-N 0.000 description 4
- NNVBILVWKLMHPC-UHFFFAOYSA-N tert-butyl n-(2-amino-4-fluoro-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound C1=C(N)C(NC(=O)OC(C)(C)C)=CC(N2CCCC2)=C1F NNVBILVWKLMHPC-UHFFFAOYSA-N 0.000 description 4
- JTJFEWDXNKYBOE-UHFFFAOYSA-N tert-butyl n-(2-nitrophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CC=C1[N+]([O-])=O JTJFEWDXNKYBOE-UHFFFAOYSA-N 0.000 description 4
- UYZHRUJEJDICNT-UHFFFAOYSA-N tert-butyl n-(4-methyl-2-nitro-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound CC1=CC([N+]([O-])=O)=C(NC(=O)OC(C)(C)C)C=C1N1CCCC1 UYZHRUJEJDICNT-UHFFFAOYSA-N 0.000 description 4
- VZQQUUOWRMHQPG-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-[methyl(propan-2-yl)amino]phenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl VZQQUUOWRMHQPG-UHFFFAOYSA-N 0.000 description 4
- NKQCIXSPRUQCPK-UHFFFAOYSA-N tert-butyl n-[2-amino-4-cyano-5-[methyl(2-methylpropyl)amino]phenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#N NKQCIXSPRUQCPK-UHFFFAOYSA-N 0.000 description 4
- ZADFCGJNPDZVLX-UHFFFAOYSA-N tert-butyl n-[2-amino-4-cyano-5-[methyl(propyl)amino]phenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#N ZADFCGJNPDZVLX-UHFFFAOYSA-N 0.000 description 4
- IZYKHDOWPOKDDY-UHFFFAOYSA-N tert-butyl n-[2-amino-4-methyl-5-[methyl(2-methylpropyl)amino]phenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C IZYKHDOWPOKDDY-UHFFFAOYSA-N 0.000 description 4
- FBTJEKMDVKZHDX-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(dimethylamino)-4-methylphenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C FBTJEKMDVKZHDX-UHFFFAOYSA-N 0.000 description 4
- HBMYBFUHFGSHSZ-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[methyl(propyl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F HBMYBFUHFGSHSZ-UHFFFAOYSA-N 0.000 description 4
- XRHYZWTWMLLKBA-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-[[3-[3-[4-(oxan-2-yloxymethyl)pyrazol-1-yl]phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CC(COC3OCCCC3)=C2)=C1 XRHYZWTWMLLKBA-UHFFFAOYSA-N 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 4
- 238000010626 work up procedure Methods 0.000 description 4
- GORVDCBAQYYSLF-UHFFFAOYSA-N (2-aminophenyl)carbamic acid Chemical compound NC1=CC=CC=C1NC(O)=O GORVDCBAQYYSLF-UHFFFAOYSA-N 0.000 description 3
- LLPVQGDNKWRPQT-UHFFFAOYSA-N (5-chloro-4-iodo-2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC(Cl)=C(I)C=C1[N+]([O-])=O LLPVQGDNKWRPQT-UHFFFAOYSA-N 0.000 description 3
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 3
- GFISDBXSWQMOND-UHFFFAOYSA-N 2,5-dimethoxyoxolane Chemical class COC1CCC(OC)O1 GFISDBXSWQMOND-UHFFFAOYSA-N 0.000 description 3
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 240000001812 Hyssopus officinalis Species 0.000 description 3
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 3
- QZRGKCOWNLSUDK-UHFFFAOYSA-N Iodochlorine Chemical compound ICl QZRGKCOWNLSUDK-UHFFFAOYSA-N 0.000 description 3
- HETCEOQFVDFGSY-UHFFFAOYSA-N Isopropenyl acetate Chemical compound CC(=C)OC(C)=O HETCEOQFVDFGSY-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 3
- 229910008066 SnC12 Inorganic materials 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- 150000001502 aryl halides Chemical class 0.000 description 3
- ATCKJLDGNXGLAO-UHFFFAOYSA-N bis(trimethylsilyl) propanedioate Chemical compound C[Si](C)(C)OC(=O)CC(=O)O[Si](C)(C)C ATCKJLDGNXGLAO-UHFFFAOYSA-N 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 150000001805 chlorine compounds Chemical group 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 3
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 3
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 239000012948 isocyanate Substances 0.000 description 3
- 150000002513 isocyanates Chemical class 0.000 description 3
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 3
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- NKGYSGGAEUCELQ-UHFFFAOYSA-N methyl 3-(1,2,4-triazol-1-yl)benzoate Chemical compound COC(=O)C1=CC=CC(N2N=CN=C2)=C1 NKGYSGGAEUCELQ-UHFFFAOYSA-N 0.000 description 3
- FXRDQWHOMXLBQD-UHFFFAOYSA-N methyl 3-(1,3-oxazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2N=COC=2)=C1 FXRDQWHOMXLBQD-UHFFFAOYSA-N 0.000 description 3
- GQGMWTKOWVKNPF-UHFFFAOYSA-N methyl 3-(2-methyl-5-propyl-1,3-oxazol-4-yl)benzoate Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C(=O)OC)=C1CCC GQGMWTKOWVKNPF-UHFFFAOYSA-N 0.000 description 3
- SNVAHEGEZKMZMQ-UHFFFAOYSA-N methyl 3-(aminocarbamothioyl)benzoate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC(=O)C1=CC=CC(C(=S)NN)=C1 SNVAHEGEZKMZMQ-UHFFFAOYSA-N 0.000 description 3
- WDFCGZDPFZYSLM-UHFFFAOYSA-N methyl 3-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoyl]benzoate Chemical compound COC(=O)C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 WDFCGZDPFZYSLM-UHFFFAOYSA-N 0.000 description 3
- MBBRSLODSVCTGY-UHFFFAOYSA-N methyl 3-carbamothioylbenzoate Chemical compound COC(=O)C1=CC=CC(C(N)=S)=C1 MBBRSLODSVCTGY-UHFFFAOYSA-N 0.000 description 3
- HXCUTXDIOYMIJT-UHFFFAOYSA-N methyl 3-pent-4-enoylbenzoate Chemical compound COC(=O)C1=CC=CC(C(=O)CCC=C)=C1 HXCUTXDIOYMIJT-UHFFFAOYSA-N 0.000 description 3
- GAKCQFDXNPITFA-UHFFFAOYSA-N methyl 3-propanoylbenzoate Chemical compound CCC(=O)C1=CC=CC(C(=O)OC)=C1 GAKCQFDXNPITFA-UHFFFAOYSA-N 0.000 description 3
- 150000002828 nitro derivatives Chemical class 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- QVBPZZKELHNMDZ-UHFFFAOYSA-M potassium;3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoate Chemical compound [K+].CC(C)(C)OC(=O)CC([O-])=O QVBPZZKELHNMDZ-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- 238000007127 saponification reaction Methods 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- GUJBVLUYJDMBKB-UHFFFAOYSA-N tert-butyl 3-[3-[4-(oxan-2-yloxymethyl)pyrazol-1-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(N2N=CC(COC3OCCCC3)=C2)=C1 GUJBVLUYJDMBKB-UHFFFAOYSA-N 0.000 description 3
- VQUJLQDYVXMACA-UHFFFAOYSA-N tert-butyl 3-oxo-3-[3-(1,3-thiazol-4-yl)phenyl]propanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2N=CSC=2)=C1 VQUJLQDYVXMACA-UHFFFAOYSA-N 0.000 description 3
- DBFFOSHTRIHRAO-UHFFFAOYSA-N tert-butyl n-(2-amino-4-methyl-5-pyrrolidin-1-ylphenyl)carbamate Chemical compound CC1=CC(N)=C(NC(=O)OC(C)(C)C)C=C1N1CCCC1 DBFFOSHTRIHRAO-UHFFFAOYSA-N 0.000 description 3
- AMALPKAIGCFWJR-UHFFFAOYSA-N tert-butyl n-(4-chloro-2-nitro-5-piperidin-1-ylphenyl)carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCCCC2)=C1Cl AMALPKAIGCFWJR-UHFFFAOYSA-N 0.000 description 3
- NBGGIMGIDJFPDI-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-(propan-2-ylamino)phenyl]carbamate Chemical compound CC(C)NC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl NBGGIMGIDJFPDI-UHFFFAOYSA-N 0.000 description 3
- FOTWLZJLVZRDQS-UHFFFAOYSA-N tert-butyl n-[2-amino-4-cyano-5-[methyl(propan-2-yl)amino]phenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#N FOTWLZJLVZRDQS-UHFFFAOYSA-N 0.000 description 3
- BIWDUNBAIDXQII-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[ethyl(methyl)amino]-4-methylphenyl]carbamate Chemical compound CCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C BIWDUNBAIDXQII-UHFFFAOYSA-N 0.000 description 3
- OWDYVWOBISSUIH-UHFFFAOYSA-N tert-butyl n-[2-nitro-5-(2,2,2-trifluoroethoxy)-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(OCC(F)(F)F)=C(C(F)(F)F)C=C1[N+]([O-])=O OWDYVWOBISSUIH-UHFFFAOYSA-N 0.000 description 3
- PCIUUFCHBGXPMZ-UHFFFAOYSA-N tert-butyl n-[4-chloro-2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-5-(dimethylamino)phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(C#N)=C1 PCIUUFCHBGXPMZ-UHFFFAOYSA-N 0.000 description 3
- NKQMESHTYIOCPN-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(2-methylpropylamino)-2-nitrophenyl]carbamate Chemical compound CC(C)CNC1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl NKQMESHTYIOCPN-UHFFFAOYSA-N 0.000 description 3
- HIJGGUTUMXRNPR-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(2-methylpropyl)amino]-2-nitrophenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl HIJGGUTUMXRNPR-UHFFFAOYSA-N 0.000 description 3
- CRWZRJODVOQKTK-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[methyl(propan-2-yl)amino]-2-nitrophenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl CRWZRJODVOQKTK-UHFFFAOYSA-N 0.000 description 3
- KOODUFBMIZYITK-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-(diethylamino)-2-nitrophenyl]carbamate Chemical compound CCN(CC)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C#N KOODUFBMIZYITK-UHFFFAOYSA-N 0.000 description 3
- QRUDPZAAJNYWAD-UHFFFAOYSA-N tert-butyl n-[4-methyl-5-[methyl(propyl)amino]-2-nitrophenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C QRUDPZAAJNYWAD-UHFFFAOYSA-N 0.000 description 3
- XBYNEZWMJVZREW-UHFFFAOYSA-N tert-butyl n-[5-(2-methylpropylamino)-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)CNC1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F XBYNEZWMJVZREW-UHFFFAOYSA-N 0.000 description 3
- TUVPLYLIYXHUOQ-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-(2-fluorophenyl)-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C1=CC=CC=C1F TUVPLYLIYXHUOQ-UHFFFAOYSA-N 0.000 description 3
- IEEXIRDZRIEEFO-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-4-methyl-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C IEEXIRDZRIEEFO-UHFFFAOYSA-N 0.000 description 3
- NRYOCASQKQZBJI-UHFFFAOYSA-N tert-butyl n-[5-[methyl(propan-2-yl)amino]-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)N(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F NRYOCASQKQZBJI-UHFFFAOYSA-N 0.000 description 3
- KVLYBUAHJPTZFY-UHFFFAOYSA-N tert-butyl n-[5-[methyl(propyl)amino]-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F KVLYBUAHJPTZFY-UHFFFAOYSA-N 0.000 description 3
- KNJCEKKBFIVAGS-UHFFFAOYSA-N tert-butyl n-[5-cyano-2-[[3-(3-cyanophenyl)-3-oxopropanoyl]amino]-4-(dimethylamino)phenyl]carbamate Chemical compound C1=C(C#N)C(N(C)C)=CC(NC(=O)CC(=O)C=2C=C(C=CC=2)C#N)=C1NC(=O)OC(C)(C)C KNJCEKKBFIVAGS-UHFFFAOYSA-N 0.000 description 3
- QCSLIRFWJPOENV-UHFFFAOYSA-N (2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1F QCSLIRFWJPOENV-UHFFFAOYSA-N 0.000 description 2
- XDDFMQJPLRZESJ-UHFFFAOYSA-N (2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC=CC=C1[N+]([O-])=O XDDFMQJPLRZESJ-UHFFFAOYSA-N 0.000 description 2
- MFQOHSPLPDWOCF-UHFFFAOYSA-N (5-chloro-4-fluoro-2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC(Cl)=C(F)C=C1[N+]([O-])=O MFQOHSPLPDWOCF-UHFFFAOYSA-N 0.000 description 2
- FZENGILVLUJGJX-NSCUHMNNSA-N (E)-acetaldehyde oxime Chemical compound C\C=N\O FZENGILVLUJGJX-NSCUHMNNSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 2
- DYOSAFQUIFEGSK-UHFFFAOYSA-N 2,5-dimethoxy-2,3-dihydrofuran Chemical compound COC1CC=C(OC)O1 DYOSAFQUIFEGSK-UHFFFAOYSA-N 0.000 description 2
- VUNAQOGRLGNALG-UHFFFAOYSA-N 2-chloro-5-nitrobenzene-1,4-diamine Chemical compound NC1=CC([N+]([O-])=O)=C(N)C=C1Cl VUNAQOGRLGNALG-UHFFFAOYSA-N 0.000 description 2
- KOHBEDRJXKOYHL-UHFFFAOYSA-N 2-methoxy-n-methylethanamine Chemical compound CNCCOC KOHBEDRJXKOYHL-UHFFFAOYSA-N 0.000 description 2
- SDTMFDGELKWGFT-UHFFFAOYSA-N 2-methylpropan-2-olate Chemical compound CC(C)(C)[O-] SDTMFDGELKWGFT-UHFFFAOYSA-N 0.000 description 2
- JFPJVTNYCURRAB-UHFFFAOYSA-N 2-nitro-n-phenylacetamide Chemical class [O-][N+](=O)CC(=O)NC1=CC=CC=C1 JFPJVTNYCURRAB-UHFFFAOYSA-N 0.000 description 2
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 2
- QIYREYQYKITJFD-UHFFFAOYSA-N 3-(2-methyl-1,3-oxazol-4-yl)benzoic acid Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C(O)=O)=C1 QIYREYQYKITJFD-UHFFFAOYSA-N 0.000 description 2
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 2
- QPUVFEMYORGPAE-UHFFFAOYSA-N 3-(hydrazinecarbonyl)benzoic acid Chemical compound NNC(=O)C1=CC=CC(C(O)=O)=C1 QPUVFEMYORGPAE-UHFFFAOYSA-N 0.000 description 2
- NDILQXVACSSLIV-UHFFFAOYSA-N 3-(triazol-1-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC(N2N=NC=C2)=C1 NDILQXVACSSLIV-UHFFFAOYSA-N 0.000 description 2
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 2
- RPESZQVUWMFBEO-UHFFFAOYSA-N 3-cyanobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(C#N)=C1 RPESZQVUWMFBEO-UHFFFAOYSA-N 0.000 description 2
- VBYDSMBICNUTKN-UHFFFAOYSA-N 3-hydrazinylbenzoic acid Chemical compound NNC1=CC=CC(C(O)=O)=C1 VBYDSMBICNUTKN-UHFFFAOYSA-N 0.000 description 2
- ADQAMBHQDIMKGM-UHFFFAOYSA-N 3-oxo-3-(3-pyrazol-1-ylphenyl)propanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CC(N2N=CC=C2)=C1 ADQAMBHQDIMKGM-UHFFFAOYSA-N 0.000 description 2
- ILVLBKPSGQKXNP-UHFFFAOYSA-N 4-[3-(2-bromoacetyl)phenyl]-8-chloro-7-(dimethylamino)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C1=CC=CC(C(=O)CBr)=C1 ILVLBKPSGQKXNP-UHFFFAOYSA-N 0.000 description 2
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 2
- AAMCWLIPRMIPBN-UHFFFAOYSA-N 5-chloro-2-nitro-4-(trifluoromethyl)aniline Chemical compound NC1=CC(Cl)=C(C(F)(F)F)C=C1[N+]([O-])=O AAMCWLIPRMIPBN-UHFFFAOYSA-N 0.000 description 2
- ZCWXYZBQDNFULS-UHFFFAOYSA-N 5-chloro-2-nitroaniline Chemical compound NC1=CC(Cl)=CC=C1[N+]([O-])=O ZCWXYZBQDNFULS-UHFFFAOYSA-N 0.000 description 2
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 239000007848 Bronsted acid Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000000094 Chronic Pain Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 101100456896 Drosophila melanogaster metl gene Proteins 0.000 description 2
- 208000012661 Dyskinesia Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 2
- 208000020564 Eye injury Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010019196 Head injury Diseases 0.000 description 2
- 208000010496 Heart Arrest Diseases 0.000 description 2
- 208000023105 Huntington disease Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 2
- 229910010082 LiAlH Inorganic materials 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 2
- 206010057852 Nicotine dependence Diseases 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 208000026251 Opioid-Related disease Diseases 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- 101150003085 Pdcl gene Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- 208000025569 Tobacco Use disease Diseases 0.000 description 2
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- OEFGUXQAZIAYFK-UHFFFAOYSA-N [2-amino-4-chloro-5-(cyclopropylmethylamino)phenyl]carbamic acid Chemical compound C1=C(NC(O)=O)C(N)=CC(Cl)=C1NCC1CC1 OEFGUXQAZIAYFK-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 208000005298 acute pain Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 150000001543 aryl boronic acids Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013058 crude material Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 238000005828 desilylation reaction Methods 0.000 description 2
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- ODCCJTMPMUFERV-UHFFFAOYSA-N ditert-butyl carbonate Chemical compound CC(C)(C)OC(=O)OC(C)(C)C ODCCJTMPMUFERV-UHFFFAOYSA-N 0.000 description 2
- HZIKYLAZZZSYKF-UHFFFAOYSA-N ethyl 2-cyanopyridine-4-carboxylate Chemical compound CCOC(=O)C1=CC=NC(C#N)=C1 HZIKYLAZZZSYKF-UHFFFAOYSA-N 0.000 description 2
- ICNWJQOZRDWOMK-UHFFFAOYSA-N ethyl 3-hydroxypropanimidate;hydrochloride Chemical compound Cl.CCOC(=N)CCO ICNWJQOZRDWOMK-UHFFFAOYSA-N 0.000 description 2
- KEHJWELPDWMNRB-UHFFFAOYSA-N ethyl 4-(3-bromophenyl)-2,4-dioxobutanoate Chemical compound CCOC(=O)C(=O)CC(=O)C1=CC=CC(Br)=C1 KEHJWELPDWMNRB-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 150000002240 furans Chemical class 0.000 description 2
- 239000003825 glutamate receptor antagonist Substances 0.000 description 2
- 239000008241 heterogeneous mixture Substances 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- CYEBJEDOHLIWNP-UHFFFAOYSA-N methanethioamide Chemical compound NC=S CYEBJEDOHLIWNP-UHFFFAOYSA-N 0.000 description 2
- XFVLSRIDRSWWBW-UHFFFAOYSA-N methyl 3-(1,3-thiazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2N=CSC=2)=C1 XFVLSRIDRSWWBW-UHFFFAOYSA-N 0.000 description 2
- BCONYJHGQGUUPJ-UHFFFAOYSA-N methyl 3-(2,2-dihydroxyacetyl)benzoate Chemical compound COC(=O)C1=CC=CC(C(=O)C(O)O)=C1 BCONYJHGQGUUPJ-UHFFFAOYSA-N 0.000 description 2
- JEQKIZSBVJVZGD-UHFFFAOYSA-N methyl 3-(2-methyl-1,3-oxazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2N=C(C)OC=2)=C1 JEQKIZSBVJVZGD-UHFFFAOYSA-N 0.000 description 2
- MUNULOKWRWVZEA-UHFFFAOYSA-N methyl 3-(2-propan-2-yl-1h-imidazol-5-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2NC(=NC=2)C(C)C)=C1 MUNULOKWRWVZEA-UHFFFAOYSA-N 0.000 description 2
- KYEBGXQJMRBXGX-UHFFFAOYSA-N methyl 3-[2-(hydroxymethyl)-5-methyl-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(CO)=N2)C)=C1 KYEBGXQJMRBXGX-UHFFFAOYSA-N 0.000 description 2
- GCRVOUCLHCAJSR-UHFFFAOYSA-N methyl 3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2SC=C(CO)N=2)=C1 GCRVOUCLHCAJSR-UHFFFAOYSA-N 0.000 description 2
- FBHMSRURHJEWJJ-UHFFFAOYSA-N methyl 3-[5-(bromomethyl)-2-methyl-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(C)=N2)CBr)=C1 FBHMSRURHJEWJJ-UHFFFAOYSA-N 0.000 description 2
- ZOTCIZYLAPBDOU-UHFFFAOYSA-N methyl 3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2OC(CO)=NN=2)=C1 ZOTCIZYLAPBDOU-UHFFFAOYSA-N 0.000 description 2
- OFJCRJNYJRXVHP-UHFFFAOYSA-N methyl 3-[5-(hydroxymethyl)-2-methyl-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(C)=N2)CO)=C1 OFJCRJNYJRXVHP-UHFFFAOYSA-N 0.000 description 2
- MNDFXDXRMYURMC-UHFFFAOYSA-N methyl 3-carbamoylbenzoate Chemical compound COC(=O)C1=CC=CC(C(N)=O)=C1 MNDFXDXRMYURMC-UHFFFAOYSA-N 0.000 description 2
- FNFWFAVDUMMRJN-UHFFFAOYSA-N methyl 3-pyrazol-1-ylbenzoate Chemical compound COC(=O)C1=CC=CC(N2N=CC=C2)=C1 FNFWFAVDUMMRJN-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 201000005040 opiate dependence Diseases 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- WVUCPRGADMCTBN-UHFFFAOYSA-M potassium;3-ethoxy-3-oxopropanoate Chemical compound [K+].CCOC(=O)CC([O-])=O WVUCPRGADMCTBN-UHFFFAOYSA-M 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000013014 purified material Substances 0.000 description 2
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- ZNJHFNUEQDVFCJ-UHFFFAOYSA-M sodium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;hydroxide Chemical compound [OH-].[Na+].OCCN1CCN(CCS(O)(=O)=O)CC1 ZNJHFNUEQDVFCJ-UHFFFAOYSA-M 0.000 description 2
- 208000020431 spinal cord injury Diseases 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- JCSBFYHNRCDUSC-UHFFFAOYSA-N tert-butyl 3-[3-(1,3-oxazol-4-yl)phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2N=COC=2)=C1 JCSBFYHNRCDUSC-UHFFFAOYSA-N 0.000 description 2
- QXKXGQLNZMEQNY-UHFFFAOYSA-N tert-butyl 3-[3-(2-methyl-1,3-oxazol-4-yl)phenyl]-3-oxopropanoate Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1 QXKXGQLNZMEQNY-UHFFFAOYSA-N 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- GMPJOZLBWVFYPE-UHFFFAOYSA-N tert-butyl n-[2-amino-4-methyl-5-[methyl(propyl)amino]phenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C GMPJOZLBWVFYPE-UHFFFAOYSA-N 0.000 description 2
- VTSJYKYERZLMEK-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(2,2,2-trifluoroethoxy)-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC(OCC(F)(F)F)=C(C(F)(F)F)C=C1N VTSJYKYERZLMEK-UHFFFAOYSA-N 0.000 description 2
- XTFQHQUHVPJOCG-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(2-methylpropylamino)-4-(trifluoromethyl)phenyl]carbamate Chemical compound CC(C)CNC1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C(F)(F)F XTFQHQUHVPJOCG-UHFFFAOYSA-N 0.000 description 2
- WIJJMYDKODJPIW-UHFFFAOYSA-N tert-butyl n-[2-amino-5-(dimethylamino)-4-(2-fluorophenyl)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C1=CC=CC=C1F WIJJMYDKODJPIW-UHFFFAOYSA-N 0.000 description 2
- IBSWABSPOIPRBR-UHFFFAOYSA-N tert-butyl n-[2-amino-5-[cyclopropyl(methyl)amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C(N)C=C(C(F)(F)F)C=1N(C)C1CC1 IBSWABSPOIPRBR-UHFFFAOYSA-N 0.000 description 2
- YQBNEQDCUXQJLE-UHFFFAOYSA-N tert-butyl n-[4-(2,3-difluorophenyl)-5-(dimethylamino)-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C1=CC=CC(F)=C1F YQBNEQDCUXQJLE-UHFFFAOYSA-N 0.000 description 2
- NITHKDSYOYKAOK-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-[ethyl(methyl)amino]-2-nitrophenyl]carbamate Chemical compound CCN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl NITHKDSYOYKAOK-UHFFFAOYSA-N 0.000 description 2
- GMCOTEWHWHJOPG-UHFFFAOYSA-N tert-butyl n-[4-cyano-5-[methyl(2-methylpropyl)amino]-2-nitrophenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C#N GMCOTEWHWHJOPG-UHFFFAOYSA-N 0.000 description 2
- FHLVGANBKJIMMN-UHFFFAOYSA-N tert-butyl n-[4-methyl-5-[methyl(2-methylpropyl)amino]-2-nitrophenyl]carbamate Chemical compound CC(C)CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C FHLVGANBKJIMMN-UHFFFAOYSA-N 0.000 description 2
- CEDKDQPPTSSGFR-UHFFFAOYSA-N tert-butyl n-[5-(azetidin-1-yl)-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C([N+]([O-])=O)C(NC(=O)OC(C)(C)C)=CC(N2CCC2)=C1C(F)(F)F CEDKDQPPTSSGFR-UHFFFAOYSA-N 0.000 description 2
- IWHHIPIHMUKMED-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-nitro-4-(2-phenylethynyl)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C#CC1=CC=CC=C1 IWHHIPIHMUKMED-UHFFFAOYSA-N 0.000 description 2
- QSOKYLAWCXMFLQ-UHFFFAOYSA-N tert-butyl n-[5-(dimethylamino)-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1C(F)(F)F QSOKYLAWCXMFLQ-UHFFFAOYSA-N 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- SZYXKFKWFYUOGZ-UHFFFAOYSA-N (2,3-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(F)=C1F SZYXKFKWFYUOGZ-UHFFFAOYSA-N 0.000 description 1
- XORPVHVDCMOJPF-UHFFFAOYSA-N (2-amino-4-chloro-5-pyrrolidin-1-ylphenyl)carbamic acid Chemical compound C1=C(NC(O)=O)C(N)=CC(Cl)=C1N1CCCC1 XORPVHVDCMOJPF-UHFFFAOYSA-N 0.000 description 1
- JNUZADQZHYFJGW-JOCHJYFZSA-N (2R)-N-[3-[5-fluoro-2-(2-fluoro-3-methylsulfonylanilino)pyrimidin-4-yl]-1H-indol-7-yl]-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide Chemical compound FC=1C(=NC(=NC=1)NC1=C(C(=CC=C1)S(=O)(=O)C)F)C1=CNC2=C(C=CC=C12)NC([C@@H](COC)N1CCN(CC1)C)=O JNUZADQZHYFJGW-JOCHJYFZSA-N 0.000 description 1
- WKTDMEXLEBELLE-UHFFFAOYSA-N (4-chloro-2-nitro-5-piperidin-1-ylphenyl)carbamic acid Chemical compound C1=C([N+]([O-])=O)C(NC(=O)O)=CC(N2CCCCC2)=C1Cl WKTDMEXLEBELLE-UHFFFAOYSA-N 0.000 description 1
- IATSTFUVEZXPCF-UHFFFAOYSA-N (4-chloro-2-nitro-5-pyrrolidin-1-ylphenyl)carbamic acid Chemical compound C1=C([N+]([O-])=O)C(NC(=O)O)=CC(N2CCCC2)=C1Cl IATSTFUVEZXPCF-UHFFFAOYSA-N 0.000 description 1
- CULDWLXLZYYWLF-UHFFFAOYSA-N (4-ethynyl-2-nitrophenyl)carbamic acid Chemical compound OC(=O)NC1=CC=C(C#C)C=C1[N+]([O-])=O CULDWLXLZYYWLF-UHFFFAOYSA-N 0.000 description 1
- ZXRMGQGMKJBWTD-UHFFFAOYSA-N (4-fluoro-2-nitro-5-pyrrolidin-1-ylphenyl)carbamic acid Chemical compound C1=C([N+]([O-])=O)C(NC(=O)O)=CC(N2CCCC2)=C1F ZXRMGQGMKJBWTD-UHFFFAOYSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 1
- 125000004521 1,3,4-thiadiazol-2-yl group Chemical group S1C(=NN=C1)* 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- LDCMTXMRTVOLKA-UHFFFAOYSA-N 1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound N1C(=O)CC=NC2=CC=CC=C21 LDCMTXMRTVOLKA-UHFFFAOYSA-N 0.000 description 1
- ODRZAZBEQWAOGU-UHFFFAOYSA-N 1,4-dioxin-2-one Chemical compound O=C1COC=CO1 ODRZAZBEQWAOGU-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- ZQHLGLKZCYAHOQ-UHFFFAOYSA-N 1-(3-methoxycarbonylphenyl)pyrazole-4-carboxylic acid Chemical compound COC(=O)C1=CC=CC(N2N=CC(=C2)C(O)=O)=C1 ZQHLGLKZCYAHOQ-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- NTZDFHQOVFYBOQ-UHFFFAOYSA-N 1-[methyl(propan-2-yl)amino]-8-(trifluoromethyl)-3H-1,5-benzodiazepin-2-one Chemical compound C(C)(C)N(C)N1C2=C(N=CCC1=O)C=CC(=C2)C(F)(F)F NTZDFHQOVFYBOQ-UHFFFAOYSA-N 0.000 description 1
- ORQVLOOOUXHZEJ-UHFFFAOYSA-N 1-cyclopropyl-n-methylmethanamine;hydrochloride Chemical compound Cl.CNCC1CC1 ORQVLOOOUXHZEJ-UHFFFAOYSA-N 0.000 description 1
- JRVZITODZAQRQM-UHFFFAOYSA-N 1-isocyanato-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1N=C=O JRVZITODZAQRQM-UHFFFAOYSA-N 0.000 description 1
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
- JYOCYCDSXDFBGV-UHFFFAOYSA-N 1h-1,4-diazepine-7-carbonitrile Chemical compound N#CC1=CC=NC=CN1 JYOCYCDSXDFBGV-UHFFFAOYSA-N 0.000 description 1
- ZCNFWVGKVHRKCD-UHFFFAOYSA-N 2,2,2-trichloro-n-(3-chlorophenyl)acetamide Chemical compound ClC1=CC=CC(NC(=O)C(Cl)(Cl)Cl)=C1 ZCNFWVGKVHRKCD-UHFFFAOYSA-N 0.000 description 1
- KIPSRYDSZQRPEA-UHFFFAOYSA-N 2,2,2-trifluoroethanamine Chemical compound NCC(F)(F)F KIPSRYDSZQRPEA-UHFFFAOYSA-N 0.000 description 1
- HRRAHRNQUBBIAR-UHFFFAOYSA-N 2,2-dimethoxyoxolane Chemical class COC1(OC)CCCO1 HRRAHRNQUBBIAR-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- UENGBOCGGKLVJJ-UHFFFAOYSA-N 2-chloro-1-(2,4-difluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CCl)C(F)=C1 UENGBOCGGKLVJJ-UHFFFAOYSA-N 0.000 description 1
- FFNVQNRYTPFDDP-UHFFFAOYSA-N 2-cyanopyridine Chemical compound N#CC1=CC=CC=N1 FFNVQNRYTPFDDP-UHFFFAOYSA-N 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- HQAXHIGPGBPPFU-UHFFFAOYSA-N 2-prop-2-ynoxyoxane Chemical compound C#CCOC1CCCCO1 HQAXHIGPGBPPFU-UHFFFAOYSA-N 0.000 description 1
- ZBWZEFLYRWANSY-UHFFFAOYSA-N 2-quinoxalin-2-ylsulfanylacetic acid Chemical compound C1=CC=CC2=NC(SCC(=O)O)=CN=C21 ZBWZEFLYRWANSY-UHFFFAOYSA-N 0.000 description 1
- OADYBXHYXPEGHX-UHFFFAOYSA-N 2h-triazol-4-ylmethanol Chemical compound OCC1=CNN=N1 OADYBXHYXPEGHX-UHFFFAOYSA-N 0.000 description 1
- XFODIAHSXPAKCW-UHFFFAOYSA-N 3-(3-cyanophenyl)-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CC(C#N)=C1 XFODIAHSXPAKCW-UHFFFAOYSA-N 0.000 description 1
- QSIJJFJVURXYMN-UHFFFAOYSA-N 3-(3-imidazol-1-ylphenyl)-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CC(N2C=NC=C2)=C1 QSIJJFJVURXYMN-UHFFFAOYSA-N 0.000 description 1
- STSDOUMXZZFNET-UHFFFAOYSA-N 3-(3-methoxycarbonylphenyl)-1,2-oxazole-4-carboxylic acid Chemical compound COC(=O)C1=CC=CC(C=2C(=CON=2)C(O)=O)=C1 STSDOUMXZZFNET-UHFFFAOYSA-N 0.000 description 1
- UYIDTQOITQDPRC-UHFFFAOYSA-N 3-(5-ethoxycarbonylpyrazol-1-yl)benzoic acid Chemical compound CCOC(=O)C1=CC=NN1C1=CC=CC(C(O)=O)=C1 UYIDTQOITQDPRC-UHFFFAOYSA-N 0.000 description 1
- WXBWXCZQGDCKSM-UHFFFAOYSA-N 3-(aminocarbamothioyl)benzoic acid Chemical compound C1=CC(=CC(=C1)C(=O)O)C(=S)NN WXBWXCZQGDCKSM-UHFFFAOYSA-N 0.000 description 1
- CHYKGWNYCLLAKL-UHFFFAOYSA-N 3-(diazepin-1-yl)pyridine-2-carbonitrile Chemical compound N#CC1=NC=CC=C1N1N=CC=CC=C1 CHYKGWNYCLLAKL-UHFFFAOYSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- VJUASUSPNMYVOR-UHFFFAOYSA-N 3-[3-[5-[(dimethylamino)methyl]triazol-1-yl]phenyl]-3-oxopropanoic acid Chemical compound CN(C)CC1=CN=NN1C1=CC=CC(C(=O)CC(O)=O)=C1 VJUASUSPNMYVOR-UHFFFAOYSA-N 0.000 description 1
- ZLXGGYUASDBBBW-UHFFFAOYSA-N 3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]benzoic acid Chemical compound OCC1=CSC(C=2C=C(C=CC=2)C(O)=O)=N1 ZLXGGYUASDBBBW-UHFFFAOYSA-N 0.000 description 1
- QAWYTFVOJUPNQF-UHFFFAOYSA-N 3-[5-(oxan-2-yloxymethyl)pyrazol-1-yl]benzoic acid Chemical compound OC(=O)C1=CC=CC(N2C(=CC=N2)COC2OCCCC2)=C1 QAWYTFVOJUPNQF-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- PBOOZQFGWNZNQE-UHFFFAOYSA-N 3-bromobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(Br)=C1 PBOOZQFGWNZNQE-UHFFFAOYSA-N 0.000 description 1
- CRRVZRDISHOQQL-UHFFFAOYSA-N 3-fluoro-4-(trifluoromethyl)aniline Chemical compound NC1=CC=C(C(F)(F)F)C(F)=C1 CRRVZRDISHOQQL-UHFFFAOYSA-N 0.000 description 1
- VKJZLGSUMISODO-UHFFFAOYSA-N 3-imidazol-1-ylbenzoyl chloride;hydrochloride Chemical compound Cl.ClC(=O)C1=CC=CC(N2C=NC=C2)=C1 VKJZLGSUMISODO-UHFFFAOYSA-N 0.000 description 1
- OAKURXIZZOAYBC-UHFFFAOYSA-N 3-oxopropanoic acid Chemical compound OC(=O)CC=O OAKURXIZZOAYBC-UHFFFAOYSA-N 0.000 description 1
- FSGTULQLEVAYRS-UHFFFAOYSA-N 4,5-dichloro-2-nitroaniline Chemical compound NC1=CC(Cl)=C(Cl)C=C1[N+]([O-])=O FSGTULQLEVAYRS-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- XAHREBHCCFVAHU-UHFFFAOYSA-N 4-amino-2-fluoro-5-nitrobenzonitrile Chemical compound NC1=CC(F)=C(C#N)C=C1[N+]([O-])=O XAHREBHCCFVAHU-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- QHHWCDNRPHPYQQ-UHFFFAOYSA-N 4-iodo-2-nitro-5-(2,2,2-trifluoroethoxy)aniline Chemical compound NC1=CC(OCC(F)(F)F)=C(I)C=C1[N+]([O-])=O QHHWCDNRPHPYQQ-UHFFFAOYSA-N 0.000 description 1
- QVCRSYXVWPPBFJ-UHFFFAOYSA-N 4-iodo-2-nitroaniline Chemical class NC1=CC=C(I)C=C1[N+]([O-])=O QVCRSYXVWPPBFJ-UHFFFAOYSA-N 0.000 description 1
- 229940044174 4-phenylenediamine Drugs 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- KWHURWOGZQWLTK-UHFFFAOYSA-N 5-chloro-4-iodo-2-nitroaniline Chemical compound NC1=CC(Cl)=C(I)C=C1[N+]([O-])=O KWHURWOGZQWLTK-UHFFFAOYSA-N 0.000 description 1
- BBWHBSDZHSQECL-UHFFFAOYSA-N 5-chloro-4-methyl-2-nitroaniline Chemical compound CC1=CC([N+]([O-])=O)=C(N)C=C1Cl BBWHBSDZHSQECL-UHFFFAOYSA-N 0.000 description 1
- UTRVMCDXCUQEEJ-UHFFFAOYSA-N 5-fluoro-2-nitro-4-(trifluoromethyl)aniline Chemical compound NC1=CC(F)=C(C(F)(F)F)C=C1[N+]([O-])=O UTRVMCDXCUQEEJ-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BOFVWSCCFHBHOW-UHFFFAOYSA-N 8-chloro-4-[3-[4-(chloromethyl)-1,3-thiazol-2-yl]phenyl]-7-(dimethylamino)-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(Cl)C(N(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=NC(CCl)=CS1 BOFVWSCCFHBHOW-UHFFFAOYSA-N 0.000 description 1
- QBSNFNKYIAYAHP-UHFFFAOYSA-N 8-methyl-7-[methyl(2-methylpropyl)amino]-4-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one Chemical compound C1C(=O)NC=2C=C(C)C(N(C)CC(C)C)=CC=2N=C1C(C=1)=CC=CC=1C1=CC(C)=NO1 QBSNFNKYIAYAHP-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 125000006847 BOC protecting group Chemical group 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- PIUCYMRNQSPLEG-UHFFFAOYSA-N COC(C1=CC(=CC=C1)C=1N=CSC1)=O.C(C)(C)(C)OC(CC(C1=CC(=CC=C1)C=1N=CSC1)=O)=O Chemical compound COC(C1=CC(=CC=C1)C=1N=CSC1)=O.C(C)(C)(C)OC(CC(C1=CC(=CC=C1)C=1N=CSC1)=O)=O PIUCYMRNQSPLEG-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VMPNXDNBICBBDI-UHFFFAOYSA-N ClNC1=CC(=C(C=C1)N)[N+](=O)[O-] Chemical compound ClNC1=CC(=C(C=C1)N)[N+](=O)[O-] VMPNXDNBICBBDI-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 1
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 description 1
- 102100036834 Metabotropic glutamate receptor 1 Human genes 0.000 description 1
- 102100038352 Metabotropic glutamate receptor 3 Human genes 0.000 description 1
- 102100038354 Metabotropic glutamate receptor 4 Human genes 0.000 description 1
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 description 1
- 102100038300 Metabotropic glutamate receptor 6 Human genes 0.000 description 1
- 102100038294 Metabotropic glutamate receptor 7 Human genes 0.000 description 1
- 102100037636 Metabotropic glutamate receptor 8 Human genes 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- GMEHFXXZSWDEDB-UHFFFAOYSA-N N-ethylthiourea Chemical compound CCNC(N)=S GMEHFXXZSWDEDB-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 101100028920 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cfp gene Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- BDYVWDMHYNGVGE-UHFFFAOYSA-N [2-(aminomethyl)cyclohexyl]methanamine Chemical compound NCC1CCCCC1CN BDYVWDMHYNGVGE-UHFFFAOYSA-N 0.000 description 1
- PBENWPXNYINQFF-UHFFFAOYSA-N [2-amino-4-(2-fluorophenyl)-5-(2,2,2-trifluoroethoxy)phenyl]carbamic acid Chemical compound C1=C(NC(O)=O)C(N)=CC(C=2C(=CC=CC=2)F)=C1OCC(F)(F)F PBENWPXNYINQFF-UHFFFAOYSA-N 0.000 description 1
- ANKQBYOEMFIBJT-UHFFFAOYSA-N [2-amino-4-chloro-5-(dimethylamino)phenyl]carbamic acid Chemical compound CN(C)C1=CC(NC(O)=O)=C(N)C=C1Cl ANKQBYOEMFIBJT-UHFFFAOYSA-N 0.000 description 1
- WAQINXUSDZOMAV-UHFFFAOYSA-N [2-amino-5-(azetidin-1-yl)-4-(trifluoromethyl)phenyl]carbamic acid Chemical compound C1=C(NC(O)=O)C(N)=CC(C(F)(F)F)=C1N1CCC1 WAQINXUSDZOMAV-UHFFFAOYSA-N 0.000 description 1
- SYEXOGBWBCDRKR-UHFFFAOYSA-N [2-amino-5-(dimethylamino)-4-(trifluoromethyl)phenyl]carbamic acid Chemical compound CN(C)C1=CC(NC(O)=O)=C(N)C=C1C(F)(F)F SYEXOGBWBCDRKR-UHFFFAOYSA-N 0.000 description 1
- KRUNGEKRLONXOT-UHFFFAOYSA-N [4-(2,3-difluorophenyl)-5-(dimethylamino)-2-nitrophenyl]carbamic acid Chemical compound CN(C)C1=CC(NC(O)=O)=C([N+]([O-])=O)C=C1C1=CC=CC(F)=C1F KRUNGEKRLONXOT-UHFFFAOYSA-N 0.000 description 1
- FVETWPPDIGYPTN-UHFFFAOYSA-N [4-(2-fluorophenyl)-2-[[3-[3-(3-methyl-1,2-oxazol-5-yl)phenyl]-3-oxopropanoyl]amino]-5-(2,2,2-trifluoroethoxy)phenyl]carbamic acid Chemical compound O1N=C(C)C=C1C1=CC=CC(C(=O)CC(=O)NC=2C(=CC(OCC(F)(F)F)=C(C=2)C=2C(=CC=CC=2)F)NC(O)=O)=C1 FVETWPPDIGYPTN-UHFFFAOYSA-N 0.000 description 1
- INIRHMXWYMPZNS-UHFFFAOYSA-N [4-chloro-5-(dimethylamino)-2-nitrophenyl]carbamic acid Chemical compound CN(C)C1=CC(NC(O)=O)=C([N+]([O-])=O)C=C1Cl INIRHMXWYMPZNS-UHFFFAOYSA-N 0.000 description 1
- OJVLOZUJNFVXHM-UHFFFAOYSA-N [4-iodo-2-nitro-5-(2,2,2-trifluoroethoxy)phenyl]carbamic acid Chemical compound OC(=O)NC1=CC(OCC(F)(F)F)=C(I)C=C1[N+]([O-])=O OJVLOZUJNFVXHM-UHFFFAOYSA-N 0.000 description 1
- BICWJZLKUDDQCS-UHFFFAOYSA-N [5-(3-bromophenyl)-1-methylpyrazol-3-yl]methanol Chemical compound CN1N=C(CO)C=C1C1=CC=CC(Br)=C1 BICWJZLKUDDQCS-UHFFFAOYSA-N 0.000 description 1
- WMOHZRASAUMJIO-UHFFFAOYSA-N [5-(3-bromophenyl)-3-methyl-1,2-oxazol-4-yl]methanol Chemical compound CC1=NOC(C=2C=C(Br)C=CC=2)=C1CO WMOHZRASAUMJIO-UHFFFAOYSA-N 0.000 description 1
- NKDGOIYKFHUUCT-UHFFFAOYSA-N [5-(dimethylamino)-2-[[3-[3-(2-methylpyrazol-3-yl)phenyl]-3-oxopropanoyl]amino]-4-(trifluoromethyl)phenyl]carbamic acid Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(O)=O)=C1NC(=O)CC(=O)C1=CC=CC(C=2N(N=CC=2)C)=C1 NKDGOIYKFHUUCT-UHFFFAOYSA-N 0.000 description 1
- LKSMKMCJWSEUAX-UHFFFAOYSA-N [5-(dimethylamino)-4-methyl-2-nitrophenyl]carbamic acid Chemical compound CN(C)C1=CC(NC(O)=O)=C([N+]([O-])=O)C=C1C LKSMKMCJWSEUAX-UHFFFAOYSA-N 0.000 description 1
- CXSMKNYHOKLNPC-UHFFFAOYSA-N [5-(hydroxymethyl)-2-nitro-4-(2-phenylethynyl)phenyl]carbamic acid Chemical compound OCC1=CC(NC(O)=O)=C([N+]([O-])=O)C=C1C#CC1=CC=CC=C1 CXSMKNYHOKLNPC-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- ZMQBBPRAZLACCW-UHFFFAOYSA-N acetic acid;dichloromethane Chemical compound ClCCl.CC(O)=O ZMQBBPRAZLACCW-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- YKDQCFXTQZGXPJ-UHFFFAOYSA-N benzyl 2-cyano-3-ethoxyprop-2-enoate Chemical compound CCOC=C(C#N)C(=O)OCC1=CC=CC=C1 YKDQCFXTQZGXPJ-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- DDKMFOUTRRODRE-UHFFFAOYSA-N chloromethanone Chemical compound Cl[C]=O DDKMFOUTRRODRE-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- HXSNGAHNYZBZTH-UHFFFAOYSA-N cyclopropylmethanamine;hydrochloride Chemical compound Cl.NCC1CC1 HXSNGAHNYZBZTH-UHFFFAOYSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- MATPZHBYOVDBLI-JJYYJPOSSA-N dcg-iv Chemical compound OC(=O)[C@@H](N)C1[C@@H](C(O)=O)[C@@H]1C(O)=O MATPZHBYOVDBLI-JJYYJPOSSA-N 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- OKGXJRGLYVRVNE-UHFFFAOYSA-N diaminomethylidenethiourea Chemical compound NC(N)=NC(N)=S OKGXJRGLYVRVNE-UHFFFAOYSA-N 0.000 description 1
- POCFBDFTJMJWLG-UHFFFAOYSA-N dihydrosinapic acid methyl ester Natural products COC(=O)CCC1=CC(OC)=C(O)C(OC)=C1 POCFBDFTJMJWLG-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- GTCBVGDJIQFBFF-AATRIKPKSA-N ethyl (e)-4-(dimethylamino)-2-oxobut-3-enoate Chemical compound CCOC(=O)C(=O)\C=C\N(C)C GTCBVGDJIQFBFF-AATRIKPKSA-N 0.000 description 1
- BNYXCUYTAHGECY-UHFFFAOYSA-N ethyl 2-(3-bromophenyl)-3-oxopropanoate Chemical compound CCOC(=O)C(C=O)C1=CC=CC(Br)=C1 BNYXCUYTAHGECY-UHFFFAOYSA-N 0.000 description 1
- HFKBJCIXEIHVKK-UHFFFAOYSA-N ethyl 3-(3-bromophenyl)-3-pyrrolidin-1-ylprop-2-enoate Chemical compound C=1C=CC(Br)=CC=1C(=CC(=O)OCC)N1CCCC1 HFKBJCIXEIHVKK-UHFFFAOYSA-N 0.000 description 1
- RDYVOLQRIFEJAZ-UHFFFAOYSA-N ethyl 3-(3-methyl-1,2-oxazol-5-yl)benzoate Chemical compound CCOC(=O)C1=CC=CC(C=2ON=C(C)C=2)=C1 RDYVOLQRIFEJAZ-UHFFFAOYSA-N 0.000 description 1
- PGNHYEASYXBVHG-UHFFFAOYSA-N ethyl 3-oxo-3-[3-(1,2,4-triazol-4-yl)phenyl]propanoate Chemical compound CCOC(=O)CC(=O)C1=CC=CC(N2C=NN=C2)=C1 PGNHYEASYXBVHG-UHFFFAOYSA-N 0.000 description 1
- GTCBVGDJIQFBFF-UHFFFAOYSA-N ethyl 4-(dimethylamino)-2-oxobut-3-enoate Chemical compound CCOC(=O)C(=O)C=CN(C)C GTCBVGDJIQFBFF-UHFFFAOYSA-N 0.000 description 1
- WJQBCAKQPSSFLF-UHFFFAOYSA-N ethyl 5-(3-bromophenyl)-1-methylpyrazole-3-carboxylate Chemical compound CN1N=C(C(=O)OCC)C=C1C1=CC=CC(Br)=C1 WJQBCAKQPSSFLF-UHFFFAOYSA-N 0.000 description 1
- PKRZEHHASBGPPG-UHFFFAOYSA-N ethyl 5-(3-bromophenyl)-3-methyl-1,2-oxazole-4-carboxylate Chemical compound CC1=NOC(C=2C=C(Br)C=CC=2)=C1C(=O)OCC PKRZEHHASBGPPG-UHFFFAOYSA-N 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- MGJURKDLIJVDEO-UHFFFAOYSA-N formaldehyde;hydrate Chemical compound O.O=C MGJURKDLIJVDEO-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 108010038445 metabotropic glutamate receptor 3 Proteins 0.000 description 1
- 108010038422 metabotropic glutamate receptor 4 Proteins 0.000 description 1
- 108010038450 metabotropic glutamate receptor 6 Proteins 0.000 description 1
- 108010038449 metabotropic glutamate receptor 7 Proteins 0.000 description 1
- 108010038448 metabotropic glutamate receptor 8 Proteins 0.000 description 1
- 108010014719 metabotropic glutamate receptor type 1 Proteins 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- VYXBNKUFCQQDDQ-UHFFFAOYSA-N methyl 2-(3-bromobenzoyl)-3-(propan-2-ylamino)prop-2-enoate Chemical compound CC(C)NC=C(C(=O)OC)C(=O)C1=CC=CC(Br)=C1 VYXBNKUFCQQDDQ-UHFFFAOYSA-N 0.000 description 1
- OIQHKKSYHZIDLX-UHFFFAOYSA-N methyl 2-(3-methyl-1,2-oxazol-5-yl)pyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC(C=2ON=C(C)C=2)=C1 OIQHKKSYHZIDLX-UHFFFAOYSA-N 0.000 description 1
- XXOKMYMXDALOEN-UHFFFAOYSA-N methyl 2-iodopyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC(I)=C1 XXOKMYMXDALOEN-UHFFFAOYSA-N 0.000 description 1
- QZEHZZXUVLRWFG-UHFFFAOYSA-N methyl 3-(2-bromo-1,1-dimethoxyethyl)benzoate Chemical compound COC(=O)C1=CC=CC(C(CBr)(OC)OC)=C1 QZEHZZXUVLRWFG-UHFFFAOYSA-N 0.000 description 1
- DGMAJENCZXAPTB-UHFFFAOYSA-N methyl 3-(2-bromopropanoyl)benzoate;methyl 3-(5-methyl-1,3-oxazol-4-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C(=O)C(C)Br)=C1.COC(=O)C1=CC=CC(C2=C(OC=N2)C)=C1 DGMAJENCZXAPTB-UHFFFAOYSA-N 0.000 description 1
- LEIJXXQQGMEHKW-UHFFFAOYSA-N methyl 3-(2-methylpyrazol-3-yl)benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(N=CC=2)C)=C1 LEIJXXQQGMEHKW-UHFFFAOYSA-N 0.000 description 1
- KZGRSYGDDBGHOO-UHFFFAOYSA-N methyl 3-(hydroxyiminomethyl)benzoate Chemical compound COC(=O)C1=CC=CC(C=NO)=C1 KZGRSYGDDBGHOO-UHFFFAOYSA-N 0.000 description 1
- PSSQBUQWZUHXSD-UHFFFAOYSA-N methyl 3-(propan-2-ylamino)prop-2-enoate Chemical compound COC(=O)C=CNC(C)C PSSQBUQWZUHXSD-UHFFFAOYSA-N 0.000 description 1
- KZGRSYGDDBGHOO-POHAHGRESA-N methyl 3-[(z)-hydroxyiminomethyl]benzoate Chemical compound COC(=O)C1=CC=CC(\C=N/O)=C1 KZGRSYGDDBGHOO-POHAHGRESA-N 0.000 description 1
- NSUKZHPOWCPFRY-UHFFFAOYSA-N methyl 3-[2-methyl-5-(oxan-2-yloxymethyl)-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC(C)=N2)COC2OCCCC2)=C1 NSUKZHPOWCPFRY-UHFFFAOYSA-N 0.000 description 1
- KUGUVCXSMYNPIW-UHFFFAOYSA-N methyl 3-[2-methyl-5-(oxan-2-yloxymethyl)pyrazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(N=C(COC3OCCCC3)C=2)C)=C1 KUGUVCXSMYNPIW-UHFFFAOYSA-N 0.000 description 1
- FXIPLAQQNNBNPC-UHFFFAOYSA-N methyl 3-[3-(methoxymethyl)-1,2-oxazol-5-yl]benzoate Chemical compound O1N=C(COC)C=C1C1=CC=CC(C(=O)OC)=C1 FXIPLAQQNNBNPC-UHFFFAOYSA-N 0.000 description 1
- RJMQKNVGFXRGTN-UHFFFAOYSA-N methyl 3-[4-(chloromethyl)-1,3-oxazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2OC=C(CCl)N=2)=C1 RJMQKNVGFXRGTN-UHFFFAOYSA-N 0.000 description 1
- ADPGNRIPFOFTRX-UHFFFAOYSA-N methyl 3-[4-(hydroxymethyl)-1,2-oxazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2C(=CON=2)CO)=C1 ADPGNRIPFOFTRX-UHFFFAOYSA-N 0.000 description 1
- QGRNIDIZWMQJOP-UHFFFAOYSA-N methyl 3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2OC=C(CO)N=2)=C1 QGRNIDIZWMQJOP-UHFFFAOYSA-N 0.000 description 1
- GGHQUXYWSROBLW-UHFFFAOYSA-N methyl 3-[4-(methoxymethyl)-2-methylpyrazol-3-yl]benzoate Chemical compound C1=NN(C)C(C=2C=C(C=CC=2)C(=O)OC)=C1COC GGHQUXYWSROBLW-UHFFFAOYSA-N 0.000 description 1
- TZFTWLWSTINBGP-UHFFFAOYSA-N methyl 3-[4-(oxan-2-yloxymethyl)-1,3-oxazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2OC=C(COC3OCCCC3)N=2)=C1 TZFTWLWSTINBGP-UHFFFAOYSA-N 0.000 description 1
- GGRYEDQOBPIMKX-UHFFFAOYSA-N methyl 3-[4-(oxan-2-yloxymethyl)-1,3-thiazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2SC=C(COC3OCCCC3)N=2)=C1 GGRYEDQOBPIMKX-UHFFFAOYSA-N 0.000 description 1
- BZCDVQIEADVFMX-UHFFFAOYSA-N methyl 3-[4-(oxan-2-yloxymethyl)-5-propyl-1,3-thiazol-2-yl]benzoate Chemical compound CCCC=1SC(C=2C=C(C=CC=2)C(=O)OC)=NC=1COC1CCCCO1 BZCDVQIEADVFMX-UHFFFAOYSA-N 0.000 description 1
- GRJKSWGQVPXVKL-UHFFFAOYSA-N methyl 3-[5-(bromomethyl)-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC=N2)CBr)=C1 GRJKSWGQVPXVKL-UHFFFAOYSA-N 0.000 description 1
- KYJZYWYCNUDCAL-UHFFFAOYSA-N methyl 3-[5-(hydroxymethyl)-2-methylpyrazol-3-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(N=C(CO)C=2)C)=C1 KYJZYWYCNUDCAL-UHFFFAOYSA-N 0.000 description 1
- AUGFTAYXXLVEEC-UHFFFAOYSA-N methyl 3-[5-(oxan-2-yloxymethyl)-1,3-thiazol-4-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C2=C(SC=N2)COC2OCCCC2)=C1 AUGFTAYXXLVEEC-UHFFFAOYSA-N 0.000 description 1
- DGMIWLZFGRRVIS-UHFFFAOYSA-N methyl 3-[5-[(dimethylamino)methyl]triazol-1-yl]benzoate Chemical compound COC(=O)C1=CC=CC(N2C(=CN=N2)CN(C)C)=C1 DGMIWLZFGRRVIS-UHFFFAOYSA-N 0.000 description 1
- MIBLEENMGJLIOC-UHFFFAOYSA-N methyl 3-[[(2-methylpropan-2-yl)oxycarbonylamino]carbamothioyl]benzoate Chemical compound COC(=O)C1=CC=CC(C(=S)NNC(=O)OC(C)(C)C)=C1 MIBLEENMGJLIOC-UHFFFAOYSA-N 0.000 description 1
- XPBHWSMZTSSEJE-UHFFFAOYSA-N methyl 3-cyanobenzoate Chemical compound COC(=O)C1=CC=CC(C#N)=C1 XPBHWSMZTSSEJE-UHFFFAOYSA-N 0.000 description 1
- OBALLCFRLYMDPH-UHFFFAOYSA-N methyl 3-hydrazinylbenzoate;hydrochloride Chemical compound Cl.COC(=O)C1=CC=CC(NN)=C1 OBALLCFRLYMDPH-UHFFFAOYSA-N 0.000 description 1
- CWINGXPWIXWOBS-UHFFFAOYSA-N methyl 3-imidazol-1-ylbenzoate Chemical compound COC(=O)C1=CC=CC(N2C=NC=C2)=C1 CWINGXPWIXWOBS-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- MVCQUSKTBSVSRY-UHFFFAOYSA-N n-(2-methoxyethylidene)hydroxylamine Chemical compound COCC=NO MVCQUSKTBSVSRY-UHFFFAOYSA-N 0.000 description 1
- YCWKZLXTHMGYAO-UHFFFAOYSA-N n-methylcyclopropanamine;hydrochloride Chemical compound Cl.CNC1CC1 YCWKZLXTHMGYAO-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- MCSAJNNLRCFZED-UHFFFAOYSA-N nitroethane Chemical compound CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 125000003145 oxazol-4-yl group Chemical group O1C=NC(=C1)* 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 210000002265 sensory receptor cell Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- OIWFSEYKZPVODW-UHFFFAOYSA-N tert-butyl 3-[3-(2-methyl-5-propyl-1,3-oxazol-4-yl)phenyl]-3-oxopropanoate Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1CCC OIWFSEYKZPVODW-UHFFFAOYSA-N 0.000 description 1
- IBAOZGUIXMWLRA-UHFFFAOYSA-N tert-butyl 3-[3-(2-methylsulfanylimidazol-1-yl)phenyl]-3-oxopropanoate Chemical compound CSC1=NC=CN1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 IBAOZGUIXMWLRA-UHFFFAOYSA-N 0.000 description 1
- WKONNHBSKSNOFO-UHFFFAOYSA-N tert-butyl 3-[3-(5-methyl-1,3-oxazol-4-yl)phenyl]-3-oxopropanoate Chemical compound O1C=NC(C=2C=C(C=CC=2)C(=O)CC(=O)OC(C)(C)C)=C1C WKONNHBSKSNOFO-UHFFFAOYSA-N 0.000 description 1
- GMAMRGUSLZPGRI-UHFFFAOYSA-N tert-butyl 3-[3-[4-(oxan-2-yloxymethyl)-1,3-oxazol-2-yl]phenyl]-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=CC(C=2OC=C(COC3OCCCC3)N=2)=C1 GMAMRGUSLZPGRI-UHFFFAOYSA-N 0.000 description 1
- ZZBJYHQQJIGQQG-UHFFFAOYSA-N tert-butyl 3-oxo-3-[3-(2-propan-2-yl-1h-imidazol-5-yl)phenyl]propanoate Chemical compound N1C(C(C)C)=NC=C1C1=CC=CC(C(=O)CC(=O)OC(C)(C)C)=C1 ZZBJYHQQJIGQQG-UHFFFAOYSA-N 0.000 description 1
- WMOVHXAZOJBABW-UHFFFAOYSA-N tert-butyl acetate Chemical compound CC(=O)OC(C)(C)C WMOVHXAZOJBABW-UHFFFAOYSA-N 0.000 description 1
- RFOPIOHIUPCDPV-UHFFFAOYSA-N tert-butyl n-[2-[[3-(2-cyanopyridin-4-yl)-3-oxopropanoyl]amino]-5-(dimethylamino)-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=NC(C#N)=C1 RFOPIOHIUPCDPV-UHFFFAOYSA-N 0.000 description 1
- MDTHMKQMDZHFHK-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-[ethyl(methyl)amino]phenyl]carbamate Chemical compound CCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl MDTHMKQMDZHFHK-UHFFFAOYSA-N 0.000 description 1
- JYFRKZBBSNUAKO-UHFFFAOYSA-N tert-butyl n-[2-amino-4-chloro-5-[methyl(propyl)amino]phenyl]carbamate Chemical compound CCCN(C)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1Cl JYFRKZBBSNUAKO-UHFFFAOYSA-N 0.000 description 1
- NBCGQUAUBRFHRC-UHFFFAOYSA-N tert-butyl n-[2-amino-4-cyano-5-(diethylamino)phenyl]carbamate Chemical compound CCN(CC)C1=CC(NC(=O)OC(C)(C)C)=C(N)C=C1C#N NBCGQUAUBRFHRC-UHFFFAOYSA-N 0.000 description 1
- PUEZFVQDVZKFKJ-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-[[3-oxo-3-[3-(1,2,4-triazol-1-yl)phenyl]propanoyl]amino]phenyl]carbamate Chemical compound C1=C(Cl)C(N(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CN=C2)=C1 PUEZFVQDVZKFKJ-UHFFFAOYSA-N 0.000 description 1
- VOLMDAFAGHTTKQ-UHFFFAOYSA-N tert-butyl n-[4-chloro-5-(dimethylamino)-2-nitrophenyl]carbamate Chemical compound CN(C)C1=CC(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C1Cl VOLMDAFAGHTTKQ-UHFFFAOYSA-N 0.000 description 1
- LCKRVRMZHMPLEV-UHFFFAOYSA-N tert-butyl n-[5-(2-methylpropylamino)-2-[[3-oxo-3-[3-(triazol-1-yl)phenyl]propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(NCC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=NC=C2)=C1 LCKRVRMZHMPLEV-UHFFFAOYSA-N 0.000 description 1
- PLLUXTVCAFEEFQ-UHFFFAOYSA-N tert-butyl n-[5-[cyclopropyl(methyl)amino]-2-nitro-4-(trifluoromethyl)phenyl]carbamate Chemical compound C=1C(NC(=O)OC(C)(C)C)=C([N+]([O-])=O)C=C(C(F)(F)F)C=1N(C)C1CC1 PLLUXTVCAFEEFQ-UHFFFAOYSA-N 0.000 description 1
- KIDWTMNUVFMTQE-UHFFFAOYSA-N tert-butyl n-[5-[methyl(2-methylpropyl)amino]-2-[[3-oxo-3-(3-pyrazol-1-ylphenyl)propanoyl]amino]-4-(trifluoromethyl)phenyl]carbamate Chemical compound C1=C(C(F)(F)F)C(N(C)CC(C)C)=CC(NC(=O)OC(C)(C)C)=C1NC(=O)CC(=O)C1=CC=CC(N2N=CC=C2)=C1 KIDWTMNUVFMTQE-UHFFFAOYSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01109125.3 | 2001-04-12 | ||
| EP01109125 | 2001-04-12 | ||
| PCT/EP2002/003644 WO2002083652A1 (en) | 2001-04-12 | 2002-04-02 | DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002312788A1 AU2002312788A1 (en) | 2003-04-10 |
| AU2002312788B2 true AU2002312788B2 (en) | 2005-11-10 |
Family
ID=8177126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002312788A Ceased AU2002312788B2 (en) | 2001-04-12 | 2002-04-02 | Dihydro-benzo [b] [1, 4] diazepin-2-one derivatives as mGluR2 antagonists II |
Country Status (37)
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1224175T3 (da) * | 1999-10-15 | 2004-07-12 | Hoffmann La Roche | Benzodiazepinderivater som metabotropiske glutamatreceptorantagonister |
| CN1281274C (zh) * | 2001-12-27 | 2006-10-25 | 大正制药株式会社 | 6-氟双环[3.1.0]己烷衍生物 |
| EP1925614A1 (en) * | 2002-03-28 | 2008-05-28 | Wisys Technology Foundation, Inc. | Anxiolytic agents with reduced sedative and ataxic effects |
| BR0308918A (pt) * | 2002-03-28 | 2005-01-04 | Wisys Technology Found Inc | Agentes ansiolìticos com efeitos sedativos e atáxicos reduzidos |
| KR100764330B1 (ko) * | 2003-07-25 | 2007-10-05 | 에프. 호프만-라 로슈 아게 | 급성 및/또는 만성 신경학적 장애의 치료를 위한mGluR2 길항제 및 AChE 억제제의 조합물 |
| US7329662B2 (en) | 2003-10-03 | 2008-02-12 | Hoffmann-La Roche Inc. | Pyrazolo-pyridine |
| US20060160823A1 (en) * | 2004-05-28 | 2006-07-20 | Leonore Witchey-Lakshmanan | Particulate-stabilized injectable pharmaceutical compositions of Posaconazole |
| ATE383361T1 (de) * | 2004-06-21 | 2008-01-15 | Hoffmann La Roche | Pyrrazolopyrimidinderivate |
| ES2365406T3 (es) * | 2005-02-11 | 2011-10-04 | F. Hoffmann-La Roche Ag | Derivados de pirazolo-pirimidina como antagonistas de mglur2. |
| EP1863818B1 (en) | 2005-03-23 | 2010-03-10 | F.Hoffmann-La Roche Ag | Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists |
| US8039637B2 (en) | 2005-06-23 | 2011-10-18 | Array Biopharma Inc. | Process for preparing benzimidazole compounds |
| ES2340321T3 (es) | 2005-09-27 | 2010-06-01 | F.Hoffmann-La Roche Ag | Oxadiazolilpirazolo-pirimidinas, como antagonistas de mglur2. |
| GB0600228D0 (en) * | 2006-01-06 | 2006-02-15 | Fermentas Uab | Inactivation method |
| AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| TW200808751A (en) * | 2006-04-13 | 2008-02-16 | Astrazeneca Ab | New compounds |
| AU2007299129A1 (en) * | 2006-09-20 | 2008-03-27 | F. Hoffmann-La Roche Ag | 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| BRPI0810655A2 (pt) | 2007-04-19 | 2014-11-04 | Hoffmann La Roche | Derivados de di-hidro-benzo[b][1,4] diazepin-2-ona sulfonamida |
| CA2697399C (en) | 2007-09-14 | 2016-01-19 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| MX2010002536A (es) | 2007-09-14 | 2010-08-10 | Ortho Mcneil Janssen Pharm | 4-fenil-3,4,5,6-tetrahidro-2h, 1'h-[1,4]bipiridinil-2'-onas 1',3'-disubstituidas. |
| US8722894B2 (en) * | 2007-09-14 | 2014-05-13 | Janssen Pharmaceuticals, Inc. | 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones |
| MX2010005110A (es) | 2007-11-14 | 2010-09-09 | Ortho Mcneil Janssen Pharm | Derivados de imidazo[1,2-a]piridina y su uso como moduladores alostericos positivos de los receptores de glutamato metabotropico 2. |
| BRPI0918055A2 (pt) | 2008-09-02 | 2015-12-01 | Addex Pharmaceuticals Sa | derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato. |
| JP5656848B2 (ja) | 2008-10-16 | 2015-01-21 | ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 代謝型グルタミン酸受容体モジュレーターとしてのインドールおよびベンゾモルホリンの誘導体 |
| CA2744138C (en) | 2008-11-28 | 2015-08-11 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| ES2409006T3 (es) | 2009-05-12 | 2013-06-24 | Janssen Pharmaceuticals Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de los receptores mGluR2 |
| SG176021A1 (en) | 2009-05-12 | 2011-12-29 | Janssen Pharmaceuticals Inc | 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| ES2603032T3 (es) | 2010-07-15 | 2017-02-23 | Bayer Intellectual Property Gmbh | Compuestos de 3-piridil-heteroarilcarboxamida como pesticidas |
| WO2012059431A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor |
| WO2012059432A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor |
| PL2649069T3 (pl) | 2010-11-08 | 2016-01-29 | Janssen Pharmaceuticals Inc | Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2 |
| WO2012062759A1 (en) | 2010-11-08 | 2012-05-18 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| US9012448B2 (en) | 2010-11-08 | 2015-04-21 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
| JP6240063B2 (ja) | 2011-04-28 | 2017-11-29 | ザ ブロード インスティテュート, インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
| JP5790195B2 (ja) * | 2011-06-22 | 2015-10-07 | セントラル硝子株式会社 | ピラゾール化合物の製造方法 |
| EP2751095B1 (en) * | 2011-08-29 | 2021-10-27 | Sanford-Burnham Medical Research Institute | Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof |
| WO2014018979A1 (en) | 2012-07-27 | 2014-01-30 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
| RU2015116749A (ru) | 2012-10-23 | 2016-12-20 | Ф. Хоффманн-Ля Рош Аг | Антагонисты mglu2/3 для лечения аутических расстройств |
| US9914717B2 (en) | 2012-12-20 | 2018-03-13 | The Broad Institute, Inc. | Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| JP6325573B2 (ja) | 2012-12-28 | 2018-05-16 | クリスタルジェノミクス・インコーポレイテッドCrystalgenomics, Inc. | Btkキナーゼ抑制剤としての2,3−ジヒドロ−イソインドール−1−オン誘導体及びこれを含む薬学的組成物 |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| PT3096790T (pt) | 2014-01-21 | 2019-10-15 | Janssen Pharmaceutica Nv | Combinações compreendendo moduladores alostéricos positivos ou agonistas ortostéricos do recetor glutamatérgico metabotrópico do subtipo 2 e seu uso |
| EA202192105A3 (ru) | 2014-02-04 | 2022-02-28 | Янссен Фармацевтика Нв | Комбинации, содержащие положительные аллостерические модуляторы или ортостерические агонисты метаботропного глутаматергического рецептора 2 подтипа, и их применение |
| LT3828173T (lt) | 2014-03-07 | 2022-11-10 | Biocryst Pharmaceuticals, Inc. | Pakeistieji pirazolai kaip žmogaus plazmos kalikreino inhibitoriai |
| CN110483525A (zh) | 2014-04-23 | 2019-11-22 | 豪夫迈·罗氏有限公司 | 用于治疗智力残疾的mglu2/3拮抗剂 |
| JP6552061B2 (ja) * | 2014-06-10 | 2019-07-31 | サンフォード−バーンハム メディカル リサーチ インスティテュート | 代謝型グルタミン酸受容体の負のアロステリックモジュレーター(nams)とその使用 |
| CN108727345B (zh) * | 2017-04-25 | 2023-06-27 | 广东东阳光药业有限公司 | 一种咪唑环中间体的制备方法 |
| CN112135610A (zh) | 2018-01-12 | 2020-12-25 | KDAc治疗股份有限公司 | 用于治疗癌症的选择性组蛋白去乙酰酶3(hdac3)抑制剂及免疫治疗剂的组合 |
| CN108586447B (zh) * | 2018-01-19 | 2021-01-29 | 中国人民解放军第四军医大学 | 一种苯二氮杂卓化合物及其制备方法和应用 |
| KR20220017898A (ko) * | 2019-06-06 | 2022-02-14 | 아르커스 바이오사이언시즈 인코포레이티드 | 아미노피리미딘 화합물의 제조 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU224435B1 (hu) * | 1995-02-09 | 2005-10-28 | EGIS Gyógyszergyár Rt. | Benzodiazepin-származékok, eljárás előállításukra, alkalmazásukra és ezeket tartalmazó gyógyászati készítmények |
| SK283859B6 (sk) * | 1995-02-09 | 2004-03-02 | Egis Gy�Gyszergy�R Rt. | 1-[2'-(Substituovaný)vinyl]-5H-2,3-benzodiazepínové deriváty, spôsob ich prípravy a medziprodukty na ich prípravu, liečivá ich obsahujúce a ich použitie |
| AU6420700A (en) * | 1999-08-05 | 2001-03-05 | Prescient Neuropharma Inc. | Novel 1,4-benzodiazepine compounds and derivatives thereof |
| TR200201023T2 (tr) * | 1999-10-15 | 2002-09-23 | F. Hoffmann-La Roche Ag | Benzodiazepin türevleri. |
| DK1224175T3 (da) * | 1999-10-15 | 2004-07-12 | Hoffmann La Roche | Benzodiazepinderivater som metabotropiske glutamatreceptorantagonister |
-
2002
- 2002-04-02 CZ CZ20033003A patent/CZ20033003A3/cs unknown
- 2002-04-02 SI SI200230163T patent/SI1379511T1/xx unknown
- 2002-04-02 YU YU79003A patent/YU79003A/sh unknown
- 2002-04-02 MX MXPA03009311A patent/MXPA03009311A/es active IP Right Grant
- 2002-04-02 NZ NZ528315A patent/NZ528315A/en unknown
- 2002-04-02 PT PT02737911T patent/PT1379511E/pt unknown
- 2002-04-02 ES ES02737911T patent/ES2246012T3/es not_active Expired - Lifetime
- 2002-04-02 CA CA002442557A patent/CA2442557C/en not_active Expired - Fee Related
- 2002-04-02 JP JP2002581408A patent/JP4071115B2/ja not_active Expired - Fee Related
- 2002-04-02 HU HU0400851A patent/HUP0400851A3/hu unknown
- 2002-04-02 DK DK02737911T patent/DK1379511T3/da active
- 2002-04-02 AU AU2002312788A patent/AU2002312788B2/en not_active Ceased
- 2002-04-02 AT AT02737911T patent/ATE299868T1/de not_active IP Right Cessation
- 2002-04-02 EP EP02737911A patent/EP1379511B1/en not_active Expired - Lifetime
- 2002-04-02 SK SK1368-2003A patent/SK13682003A3/sk unknown
- 2002-04-02 PL PL02367064A patent/PL367064A1/xx not_active Application Discontinuation
- 2002-04-02 WO PCT/EP2002/003644 patent/WO2002083652A1/en not_active Ceased
- 2002-04-02 BR BR0208891-6A patent/BR0208891A/pt not_active Application Discontinuation
- 2002-04-02 IL IL15787302A patent/IL157873A0/xx active IP Right Grant
- 2002-04-02 DE DE60205100T patent/DE60205100T2/de not_active Expired - Lifetime
- 2002-04-02 HR HR20030792A patent/HRP20030792A2/hr not_active Application Discontinuation
- 2002-04-02 CN CNB028081811A patent/CN1264825C/zh not_active Expired - Fee Related
- 2002-04-02 RU RU2003130637/04A patent/RU2263112C2/ru not_active IP Right Cessation
- 2002-04-02 KR KR1020037013300A patent/KR100566171B1/ko not_active Expired - Fee Related
- 2002-04-03 US US10/115,826 patent/US6544985B2/en not_active Expired - Fee Related
- 2002-04-09 PA PA20028543301A patent/PA8543301A1/es unknown
- 2002-04-09 AR ARP020101290A patent/AR035816A1/es not_active Application Discontinuation
- 2002-04-10 PE PE2002000291A patent/PE20021041A1/es not_active Application Discontinuation
- 2002-04-10 JO JO200232A patent/JO2285B1/en active
- 2002-04-11 GT GT200200073A patent/GT200200073A/es unknown
- 2002-04-11 MY MYPI20021345A patent/MY140271A/en unknown
- 2002-04-11 UY UY27258A patent/UY27258A1/es not_active Application Discontinuation
-
2003
- 2003-09-11 IL IL157873A patent/IL157873A/en not_active IP Right Cessation
- 2003-09-16 ZA ZA200307243A patent/ZA200307243B/en unknown
- 2003-10-08 MA MA27346A patent/MA27012A1/fr unknown
- 2003-10-08 EC EC2003004797A patent/ECSP034797A/es unknown
- 2003-10-10 NO NO20034576A patent/NO20034576L/no not_active Application Discontinuation
- 2003-10-10 BG BG108254A patent/BG108254A/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002312788B2 (en) | Dihydro-benzo [b] [1, 4] diazepin-2-one derivatives as mGluR2 antagonists II | |
| US6548495B2 (en) | Dihydro-benzo [B] [1,4] diazepin-2-one derivatives | |
| AU2002312788A1 (en) | Dihydro-benzo [b] [1, 4] diazepin-2-one derivatives as mGluR2 antagonists II | |
| CA2386980C (en) | Benzodiazepine derivatives for use in acute or chronic neurological disorders | |
| AU2002310912A1 (en) | Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mGluR2 antagonists I |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |